Potential of GLP-1 Agonists To Help Patients with Binge Eating Disorders
Live Webinar
Wed, Apr 22, 2026
12:00 PM – 1:00 PM EDT
Description
The course examines the intersection of GLP-1 and binge eating behaviors. The course will start with a description of the many roles of GLP-1 in the body including eating behaviors and metabolism. A potential link between low GLP-1 and the development of binge eating behaviors will then be discussed. The second half of the presentation will review the FDA approved indications for GLP-1 medications and outline the potential use of GLP-1 medications to treat patients with conditions including Bulimia Nervosa and Binge Eating Disorder. An advocate with lived experience will then share their experience with the medication.
Educational Goal
The education goal of this webinar is to understand the link between GLP-1 signaling and binge eating behaviors. Also, to discuss the potential use of GLP-1 medications to treat patients with binge eating disorders.
Learning Objectives
Participants will be able to:
- Outline the functions of GLP-1 after a meal within the body
- Describe some of the genetic pathways linked to the risk of developing binge eating behaviors
- Discuss expected benefits vs, potential risks of GLP-1 medications for patients with eating disorders
Target Audience
- Addiction Professional
- Counselor
- Dietitian
- Marriage & Family Therapist
- Nurse
- Nutritionist
- Physician
- Psychologist
- Social Worker
Presenters
Susan L. McElroy, MD is internationally known for her research in bipolar disorder, eating disorders, obesity, impulse control disorders and pharmacology. She is the author of over 500 scientific papers in leading medical journals and was the 8th most cited scientist in the world published in the fields of psychiatry and psychology since 1996. She has also authored over 130 reviews and chapters in major psychiatric textbooks. Dr. McElroy is the editor of 4 scientific books and serves on the editorial board of the Journal of Clinical Psychiatry. As Chief Research Officer she currently oversees multiple ongoing studies in mood, anxiety, eating and impulse control disorders, genetics and psychopharmacology. She has received funding for her research from National Institute of Mental Health, Agency for Healthcare quality, the Stanley Foundation, and industry. Dr. McElroy has been the recipient of numerous awards and honors including being named to the Research.com “Best Female Scientists in the United States 2024 Ranking” for her contributions to the advancement of science. Dr. McElroy is ranked #105 in the United States among Best Female Scientists for 2024. She is recognized among the Best Mental Health Experts by Good Housekeeping Magazine; Best Doctors in America, a directory of the top one percent of physicians in the United States as rated by their peers; Top Doctors in Cincinnati by Cincinnati Magazine; Best Doctors in Dayton by the Dayton Business Courier; and, as one of America’s Top Psychiatrists, by the Consumer Research Council. Additionally, she was a recipient of the Phillip L. Isenberg Teaching Award for dedication and excellence in the education of residents, McLean Hospital and Harvard Medical School; the Golden Apple Award for excellence in teaching of residents, University of Cincinnati College of Medicine; and a co-recipient of the Gerald L. Klerman Young Investigator Award of the National Depressive and Manic Depressive Association.
Michael Lutter, MD/PhD is a physician-scientist who has worked in the fields of eating disorders, depression, and anxiety since 2007. After completing combined MD and PhD training and Psychiatry Residency at UT Southwestern, he ran a research program on the genetic and neurobiological basis of eating disorders from 2008-2016 before transitioning to full time clinical care in 2016. In 2019, he started Precision Psychiatry to help bring innovative treatments to patients with eating disorders and related conditions. He has published one book, 30 original research papers, and written 8 review articles.
Paige Gordon